Project Grant R21DA062256
Award Date
9/30/24
Completion Date
8/31/26
Dollars Obligated
$994K
Federal Agency
National Institute on Drug Abuse
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
Massachusetts, USA
Similar Awards
This federal Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) is intended to develop and evaluate the efficacy of a universal overdose prevention intervention to be delivered in primary care settings. The $2,467,574 award will fund a pilot two-arm cluster randomized controlled trial at Boston Medical Center to assess the acceptability and feasibility of the intervention for providers and youth ages 13-26. The...
This $1,717,104 Project Grant award from the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) will support a 3-year community-engaged effort to adapt, produce, and pilot test a written "Youth Overdose Prevention Toolkit" for use by clinicians in pediatric healthcare settings. The toolkit will provide practical guidance on delivering evidence-based interventions such as naloxone distribution, drug testing strips, harm reduction education, and...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $431,750 to Rutgers, The State University of New Jersey to conduct research on informing national overdose prevention and treatment strategies for high-risk adolescents. The key objectives of this 2-year project are to: 1) estimate the prevalence of adolescent nonfatal drug overdose and identify high-risk demographic and clinical subgroups,...
This Project Grant award of $2,316,128.00 from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to design tailored harm reduction strategies to address the opioid overdose crisis across six distinct jurisdictions. The project, titled "REVERSING OVERDOSE EPIDEMICS THROUGH SIMULATION, COLLABORATION, AND UNIFIED EFFORTS (RESCUE)", will collaborate with health departments and community partners to assess the...
This Project Grant award of $1,607,146.00 from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) supports the development of a technology-based intervention to encourage drug checking, distribution of harm reduction supplies, and linkage to services for people who use drugs. The project, titled "Together Against Overdose: Community Developed Technology to Encourage Drug Checking, Distribution of Harm Reduction Supplies, and...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the federal Drug Use and Addiction Research Programs (CFDA 93.279), is intended to investigate whether a pharmacist-integrated model of opioid use disorder (OUD) treatment can increase naloxone co-prescribing in primary care. The $193,336 award to Trustees of Dartmouth College will fund a research project with three aims: (1) describing federal, state, and clinic-level policies and OUD interventions impacting...
This federal Project Grant award of $1,948,634.00 from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) aims to adapt and test a smartphone-based mobile health (mHealth) intervention to reduce overdose risk among people who engage in polysubstance use. The study will build on previous research findings on polysubstance use patterns to develop the "OD-CHESS" intervention by adapting an existing substance use disorder...
The National Institute on Drug Abuse (NIDA) awarded a Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) totaling $1,499,606.00 to the Dartmouth-Hitchcock Clinic, doing business as Dartmouth-Hitchcock Obligated Group, with a project period from September 30, 2024 to July 31, 2029. The goal of this project is to characterize health outcomes from birth to 5 years of age in children born to individuals with opioid use disorder, identify disparities across populations,...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under CFDA 93.279 Drug Use and Addiction Research Programs, provides $3,503,736 to Seattle Children's Hospital (doing business as Seattle Children's Research Institute) to develop and test a multilevel substance use disorder (SUD) and overdose prevention strategy for rural youth involved in county juvenile court systems. The project aims to collaboratively co-design the prevention strategy and an implementation...
This Project Grant award from the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) provides $193,752 to Boston Medical Center Corporation to implement and evaluate a video-coaching intervention called THRIVE to promote positive parenting behaviors among mothers with opioid use disorder (OUD). The goal is to test the effectiveness of this intervention in improving parenting and reducing child behavior problems for preschool-aged children, as well as...